The Guardian reports that new AI-powered blood tests are being trialled by NHS trusts as a potential alternative to a more intrusive diagnostic procedure for some women with suspected womb (endometrial) cancer. The test is designed to reduce the need for transvaginal ultrasound scanning in certain cases.
The reports say that in England, around 90,000 postmenopausal women each year are referred by their GPs for investigation after experiencing heavy or abnormal bleeding. At present, many of these patients undergo examinations that can be uncomfortable or invasive as part of the diagnostic pathway.
According to the coverage, the AI blood test is being assessed by two NHS trusts, with the goal of improving the assessment process by using blood-based results to help determine who may need further investigation. The reports describe the trial as a step toward sparing some patients the discomfort associated with current procedures, while still supporting clinicians in identifying potential cancer cases.
